Elhízás: vizsgálatok itt: Puerto Rico
26 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- San Juan
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleHome Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Where
- San Juan
- Életkor
- 18 év to 99 év
- People
- 230 worldwide
- Run by
- Amgen
See details and how to joinNCT07871409 - 3. fázisTaking peopleEfficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Where
- Ponce
- Életkor
- 18 év to 99 év
- People
- 300 worldwide
- Run by
- Amgen
See details and how to joinNCT07575399 - 3. fázisTaking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- Ponce, San Juan
- Életkor
- 18 év and over
- People
- 2001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - 3. fázisNot yet taking people in Puerto RicoA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Ponce
- Életkor
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - 2. fázisTaking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Bayamón, San Juan
- Életkor
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - 3. fázisTaking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- San Juan
- Életkor
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - 3. fázisTaking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- San Juan
- Életkor
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Caguas, Dorado
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleEfficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Dorado, San Juan
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Bayamón, Guaynabo
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- San Juan
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - 2. fázisTaking peopleA Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Where
- Dorado, Vega Baja
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07783802 - 3. fázisNot yet taking people in Puerto RicoA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Ponce, San Juan
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 3. fázisNot yet taking people in Puerto RicoA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Dorado, Ponce, San Juan
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bayamón
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 2. fázisTaking peopleSafety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Where
- Bayamón, Guaynabo, San Juan
- Életkor
- 18 év to 75 év
- People
- 360 worldwide
- Run by
- AbbVie
See details and how to joinNCT07752979 - 3. fázisNot yet taking people in Puerto RicoA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Humacao
- Életkor
- 45 év to 64 év
- People
- 8500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Where
- San Juan
- Életkor
- 18 év to 99 év
- People
- 950 worldwide
- Run by
- Amgen
See details and how to joinNCT07684144 · EU 2025-524788-19-00 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Where
- Ponce, San Juan
- Életkor
- 18 év to 99 év
- People
- 3200 worldwide
- Run by
- Amgen
See details and how to joinNCT07684235 - 3. fázisTaking peopleA Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
- Where
- San Juan
- Életkor
- 12 év to 17 év
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06439277 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Dorado, Vega Baja
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - 3. fázisTaking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- San Juan
- Életkor
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - 3. fázisTaking peopleAMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Where
- San Juan
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07509307 · EU 2024-520445-23-00 - No phaseTaking peopleCulturally Adapted Dietary Clinical Trial in PR
- Where
- San Juan
- Életkor
- 30 év to 65 év
- People
- 250
- Run by
- Harvard School of Public Health (HSPH)
See details and how to joinNCT05962372